Precludes Manufacturing Facility Expansion Planned for This Year

MORTON GROVE, Ill.–Regis Technologies, Inc. is proud to announce the opening of its new 15,000-square-foot Analytical Development and Quality Control (QC) laboratory at the existing site. Adding to the laboratory’s already full complement of analytical equipment is a new 400 MHz Bruker NMR. The expanded QC laboratory provides the most up-to-date technology in a first-rate facility for robust QC services for quality GMP custom manufacturing and separations of active pharmaceutical ingredients (API) and nutraceuticals.

The completion of the new QC laboratory began in September 2008 as a prerequisite to the next facilities expansion—a 30,000-sq-foot manufacturing facility that is scheduled to begin this year. Committed to continual improvement, these expansions follow a string of earlier facility projects. Early in 2007, Regis brought its Supercritical Fluid Chromatography (SFC) group online for preparative scale separations of natural products and chiral separations from gram to multi-kilo separations. In 2006, Regis opened its new non-GMP laboratories.

About Regis Technologies, Inc.

Regis Technologies, Inc. is a privately held company that provides cGMP and non-GMP synthesis and separations services to the pharmaceutical, biotechnology, and other industries worldwide. Regis partners with these organizations to provide synthesis services including methods development, scale-up, and manufacture of complex, multi-step custom synthetic products. Regis provides innovative chromatography products and services, especially those with a chiral emphasis, through the utilization of our extensive organic expertise and its collegiate collaborations.